HeimBAX • NYSE
add
Baxter International Inc
29,99 $
Eftir lokun(0,13%)-0,040
29,95 $
Lokað: 23. jún., 18:46:47 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
29,99 $
Dagbil
29,32 $ - 30,10 $
Árabil
26,25 $ - 40,49 $
Markaðsvirði
15,39 ma. USD
Meðalmagn
3,51 m.
V/H-hlutf.
-
A/V-hlutfall
2,27%
Aðalkauphöll
NYSE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 2,62 ma. | 5,42% |
Rekstrarkostnaður | 732,00 m. | -9,85% |
Nettótekjur | 126,00 m. | 240,54% |
Hagnaðarhlutfall | 4,80 | 222,15% |
Hagnaður á hvern hlut | 0,55 | -15,38% |
EBITDA | 503,00 m. | 16,17% |
Virkt skatthlutfall | 2.233,33% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 2,29 ma. | -24,19% |
Heildareignir | 21,30 ma. | -23,33% |
Heildarskuldir | 14,25 ma. | -27,12% |
Eigið fé alls | 7,05 ma. | — |
Útistandandi hlutabréf | 513,17 m. | — |
Eiginfjárgengi | 2,17 | — |
Arðsemi eigna | 2,72% | — |
Ávöxtun eigin fjár | 3,38% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 126,00 m. | 240,54% |
Handbært fé frá rekstri | -193,00 m. | -218,40% |
Reiðufé frá fjárfestingum | 3,26 ma. | 2.066,87% |
Reiðufé frá fjármögnun | -3,23 ma. | -2.204,29% |
Breyting á handbæru fé | -118,00 m. | 29,76% |
Frjálst peningaflæði | 1,73 ma. | 395,14% |
Um
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Framkvæmdastjóri
Stofnsett
1931
Höfuðstöðvar
Vefsvæði
Starfsfólk
38.000
